Topical Skin Care Compositions

A topical skin care composition with natural oils and vitamins addresses the ineffectiveness and irritation issues of existing anti-redness creams by stabilizing and soothing the skin, reducing redness and irritation effectively.

JP7592133B2Active Publication Date: 2024-11-29OCUSOFT INC
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2023142791
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-03-09
Filing Date
2023-09-04
Publication Date
2024-11-29
Estimated Expiration
2039-03-07

AI Technical Summary

Technical Problem

Existing anti-redness creams are often ineffective, unstable, cause skin irritation, or contain harmful steroids, failing to address the root cause of skin redness and irritation.

Method used

A topical skin care composition comprising a dermatologically acceptable vehicle with natural oils, vitamins, and specific ingredients like salicyloyl phytosphingosine, aloe vera, and hyaluronic acid, formulated to reduce skin redness and irritation without causing harm.

Benefits of technology

The composition effectively reduces skin redness and irritation, promotes skin hydration, and maintains skin health without causing side effects, providing long-term symptom relief and improved skin texture.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

To provide compositions and methods for treating skin redness.SOLUTION: According to an embodiment, the invention is a topical skin care composition having a dermatologically acceptable vehicle, such as, water and a plurality of ingredients dissolved in the vehicle. The ingredients include: a blend of natural oils; a plurality of vitamins; and 0.1 to 1 wt% salicyloyl phytosphingosine. The composition is unsuitable for application on the eyelids or eye area. The blend of natural oils includes: aloe barbadensis leaf juice extract; cocos nucifera (coconut oil); hydrolyzed glycosaminoglycans; and caprylic / capric triglycerides. The plurality of vitamins is selected from a group consisting of vitamin C, vitamin E, salts / derivatives of vitamin C and vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins includes: sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates generally to the field of topical formulations used to treat skin redness. [Background technology]

[0002] Skin redness is a common symptom. Skin redness can be caused by rosacea, skin allergies, use of certain skin care products or treatments, cosmetic procedures, exercise, and sometimes underlying medical conditions. For example, rosacea can cause redness and visible blood vessels on the face and can also cause small red pus-filled pimples. These signs or symptoms may flare up over a period of weeks to months and then subside for a period of time. Although redness may not necessarily be a cause for concern, it can be embarrassing, annoying, and uncomfortable for those who suffer from this skin condition.

[0003] Anti-redness creams are commonly used to stop irritation and moisturize the skin. However, not all anti-redness creams are effective or contain a compound that can treat the underlying cause of skin redness. Some anti-redness creams contain steroids and other ingredients that can cause skin thinning if used daily for consecutive weeks. Some moisturizers are unstable and cause skin irritation or have insufficient moisturizing capacity. Summary of the Invention [Problem to be solved by the invention]

[0004] Therefore, there is a need for a stable composition that reduces skin redness and skin inflammation.The composition should be free of steroids or other similar substances.The composition should also moisturize and soothe the skin without causing any irritation or other harmful side effects. [Means for solving the problem]

[0005] According to one embodiment, the present invention is a topical skin care composition having a dermatologically acceptable vehicle, such as water, and a plurality of ingredients dissolved in the vehicle. The plurality of ingredients comprises a natural oil blend; a plurality of vitamins; and 0.1-1 wt% salicyloyl phytosphingosine. The composition is not suitable for application to the eyelid or eye area. The natural oil blend comprises an aloe vera leaf juice extract; a plurality of coconut oil; a hydrolyzed glycosaminoglycan; and a tri(caprylic / capric)glyceryl. The plurality of vitamins is selected from the group consisting of vitamin C, vitamin E, a salt / derivative of vitamin C, a salt / derivative of vitamin E, and mixtures thereof. In one aspect, the plurality of vitamins comprises sodium ascorbyl phosphate; disodium lauriminodipropionate tocopheryl phosphate; and jojoba oil. The plurality of ingredients further comprises (A) dried neem leaf extract (Melia azadirachta); and (B) an acetylated tetrapeptide. The plurality of ingredients further comprises a thickener. The thickening agent is selected from the group consisting of polyacrylamide, C13-14 isoparaffin, laureth-7, and mixtures thereof.The components further include salts of: (A) hyaluronic acid; and (B) glycyrrhizic acid.

[0006] In one embodiment, the topical skin care composition comprises spray-dried powdered aloe vera; coconut oil; dried neem leaf extract (melia azadirachta); acetyl tetrapeptide-40; sodium hyaluronate; dipotassium glycyrrhizinate; about 0.2 wt% salicyloyl phytosphingosine; sodium ascorbyl phosphate; and water. The composition further comprises a thickening agent selected from the group consisting of polyacrylamide, C13-14 isoparaffin, laureth-7, and mixtures thereof. The composition further comprises hydrolyzed glycosaminoglycan. The composition comprises disodium lauriminodipropionate tocopheryl phosphate.

[0007] The composition is in a form selected from the group consisting of a lotion, a cream, a serum, a gel, a stick, a spray, an ointment, a liquid wash, a foam, and a mousse. The composition has a viscosity of 30,000-50,000 cPs at 25° C. The composition has a pH of between 4.5-6.0.

[0008] In another embodiment, a method for treating a person with skin redness comprises administering an effective amount of a topical skin care composition as described herein; and allowing said composition to remain on the skin.In some embodiments, the skin care composition can be left on the skin as a residual formulation without the need for rinsing.The composition can be administered for 60 days to cause a reduction in skin redness.In one aspect, the method further comprises pre-cleaning the skin with a non-pore-clogging composition before administering said topical skin care composition.

[0009] In yet another embodiment, the present invention is a kit comprising: (A) a first container containing an anti-redness composition, the anti-redness composition comprising about 7-12 weight percent (wt%) Aloe vera leaf juice extract; about 3-9 wt% cocos nucifera (coconut oil); about 1-4 wt% vitamin E and / or a derivative of vitamin E; and about 0.1-1 wt% salicyloyl phytosphingosine; and (B) a second container containing a second composition, the second composition being a non-pore-clogging cleanser, the cleanser comprising PEG-80 sorbitan laurate; sodium trideceth sulfate; cocamidopropyl hydroxysultaine; PEG-150 distearate; sodium lauroamphodiacetate; sodium laureth-13 carboxylate; and PEG-15 cocopolyamine. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The terms and phrases "invention," "the present invention," "the present invention," and similar terms and phrases, as used herein, are open-ended and are not intended to limit the subject matter to any single embodiment, but rather, encompass all possible embodiments that are described.

[0011] As used herein, all weight percents (wt%) are based on the total wt% of the skin care composition unless otherwise specified. Additionally, all composition percentages are based on a total equal to 100 wt% unless otherwise specified.

[0012] The compositions and methods of using them may "comprise" or "consist essentially of" or "consist of" any of the components or steps disclosed throughout this specification. As used in this specification and claims, the words "comprising" (and any variations thereof), "having" (and any variations thereof), "including" (and any variations thereof), or "containing" (and any variations thereof) are inclusive or open-ended and may include the components of the invention and do not exclude other components or elements described herein. In the claims and / or specification, the use of the word "a" or "an" when used in conjunction with the term "comprising" may mean "one," but is also consistent with the meaning of "one or more," "at least one," and "one or more than one." As used herein, "consisting essentially of" means that the invention may contain additional ingredients in addition to those recited in the claims, provided that the additional ingredients do not materially alter the basic and novel characteristics of the claimed invention. Generally, such additional ingredients may be absent entirely or present only in minor amounts. However, the composition may contain up to about 10% by weight of materials that may materially alter the basic and novel characteristics of the invention, so long as the usefulness (as opposed to the degree of usefulness) of the composition is maintained.

[0013] All ranges described herein are inclusive of both endpoints, including those that describe a range "between" two values. Terms such as "about," "generally," and "substantially" should be construed as modifying a term or value such that it is not absolute. Such terms will be defined by the context and terms they modify as understood by those of skill in the art. In one non-limiting embodiment, the terms are defined to be within 5%, more preferably within 1%, and most preferably within 0.5%. The term "substantially" and variations thereof are defined as being largely, but not necessarily entirely, of what is specified as understood by those of skill in the art, and in one non-limiting embodiment, substantially refers to a range of 0.5%-5%.

[0014] As used herein, the term "effective amount" of a composition refers to an amount sufficient to induce a desired biological response. As will be appreciated by those skilled in the art, the effective amount of a substance may vary depending on factors such as the desired biological endpoint, the patient, and the like. In some embodiments, a therapeutically effective amount of a composition is an amount sufficient to treat, inhibit, reduce, prevent, and / or delay one or more symptoms of skin redness and skin inflammation when administered to a subject suffering from or susceptible to a disease, illness, and / or condition. The terms "treat" or "relieve" or any variation of these terms include a measurable reduction in skin redness. For example, an effective amount / therapeutically effective amount of a composition for treating skin redness is an amount that reduces, improves, alleviates, inhibits, prevents, delays the onset of, reduces the severity of, and / or reduces the incidence of one or more symptoms or characteristics associated with skin redness and inflammation.

[0015] Skin care products are used to obtain healthy and attractive skin. The present invention provides a topical skin care composition containing salicyloyl phytosphingosine, natural oils and vitamins. The composition can effectively reduce / improve redness, spotty / blemished appearance of skin and inflammation. The composition can promote improvement of skin texture, such as skin elasticity, restore flexibility, reduce peeling, thereby minimizing signs of aging. Certain embodiments of the skin care composition have anti-inflammatory properties, including antibacterial and antifungal properties. The composition further promotes moisturization of the skin to maintain the skin's natural balance.

[0016] As used herein, the terms "skin care composition," "product," "composition," and similar words, including plural terms, may be used interchangeably. Specifically, the term skin care composition includes compositions that may be rubbed, spread, introduced, or otherwise applied to the skin or any portion thereof to reduce redness of the skin. The term "skin care composition" and other terms specifically include topical compositions for application to human skin. The term "topical application" refers to applying the skin care composition to the surface of the skin.

[0017] The present invention addresses a problem that has not been adequately addressed in the prior art and provides a solution to that problem that differs from the prior art. Each ingredient (and its proportions) is carefully selected to treat skin redness and irritation. Some of the embodiments specifically treat skin conditions caused by one or more microorganisms, such as E. coli, P. aeruginosa, S. aureus, C. albicans, A. brasiliensis, and other microorganisms. The skin care composition may be used to reduce skin redness and inflammation due to rosacea, allergic reactions, excessive immune responses, and cosmetic procedures. Preferably, the skin care composition of the present invention is made to dry quickly and cleanly after application of a normal amount to the skin without leaving any visible residue or significant tackiness. The skin care composition is stable and made to avoid excessive toxicity, incompatibility, or allergic reactions when applied to the skin. The topical skin care composition of the present invention may have a viscosity selected to avoid significant dripping or pooling after application to the skin.

[0018] Advantageously, the skin care composition comprises a dermatologically acceptable vehicle and one or more ingredients dissolved in the vehicle. The ingredients are selected to be compatible with and stable in the selected vehicle. In one embodiment, the vehicle comprises water. The water can be distilled or deionized water. However, other suitable vehicles such as alcohol or propylene glycol can also be used. The dissolved ingredients include a natural oil blend, multiple vitamins, and sphingoid lipids.

[0019] Natural oils or moisturizers include, but are not limited to, aloe barbadensis leaf juice or aloe vera, cocos nucifera (coconut oil), glycosaminoglycans, hydrolyzed glycosaminoglycans and caprylic / capric triglyceride. Aloe vera improves the appearance of dry or damaged skin by reducing flaking and restoring softness. Aloe is generally obtained from the leaves of the aloe plant. Aloe improves wound healing and skin inflammation. Cocos nucifera (coconut) oil is a skin conditioning agent that promotes skin elasticity. Hydrolyzed glycosaminoglycans act as a moisturizer and conditioning agent. Hydrolyzed glycosaminoglycans efficiently bind water, increasing deep hydration and improving skin elasticity and firmness. Caprylic / capric triglyceride is a skin conditioning agent derived from coconut oil.

[0020] The skin care composition further comprises one or more vitamins or vitamin derivatives. For example, the composition may comprise a source of vitamin C and vitamin E, such as ascorbic acid or a salt thereof, tocopheryl phosphate or tocopheryl acetate, and Simmondsia Chinensis (jojoba) seed oil. In one embodiment, the skin care composition comprises sodium ascorbyl phosphate, disodium lauriminodipropionate tocopheryl phosphate (DLTP), and jojoba oil. Sodium ascorbyl phosphate provides vitamin C, an essential nutrient required for collagen production, tissue repair, and neurotransmitter synthesis. DLTP is isolated from vitamin E. DLTP is used in acne treatment, scar treatment, rosacea treatment, and as a moisturizer, as a conditioner ingredient, as a sunscreen ingredient, and for anti-aging. DLTP. When applied to inflamed areas, it can effectively promote the reduction of skin redness and inflammation, and can reduce skin inflammation. Jojoba seed oil is a skin conditioning agent or emollient. Jojoba seed oil is antibacterial and contains vitamin E.

[0021] Sphingoid lipids include antimicrobial, anti-inflammatory, and anti-irritant agents, such as phytosphingosine (PSG) or its derivatives. The term "anti-irritant" as used herein is an agent that prevents or reduces pain, irritation, or inflammation of a body part, such as the skin. PSG is a water-binding agent that mimics the natural lipid layer of the outer epidermis to increase moisture retention throughout the day. PSG has anti-redness and skin tightening properties, and can inhibit microorganisms. Advantageously, PSG has both antimicrobial and wound healing properties, and functions as an anti-inflammatory agent at concentrations as low as 0.1%. In certain embodiments, the skin care composition comprises PSG esterified with salicylic acid and its derivatives.

[0022] Salicyloyl PSG is a derivative of skin-identical PSG of natural origin, covalently bonded to salicylic acid. Salicyloyl PSG and its derivatives contribute to skin repair and skin renewal, prevention of water loss from the skin, control of epidermal cell growth and minimizing signs of aging by supporting epidermal cell differentiation and apoptosis, improving the condition of mature or photoaged dermis by promoting collagen synthesis and reducing its degradation, strengthening the dermal-epidermal junction, and soothing irritated skin.

[0023] The skin care composition may advantageously contain other ingredients such as, but not limited to, Melia azadirachta leaf extract, hyaluronic acid or its salts, glycyrrhizin or glycyrrhizic acid or glycyrrhizic acid or its salts, tocopherol and tocopherol esters.

[0024] Melia azadirachta (neem leaf) extract has insecticidal, nematicidal, fungicidal, bactericidal, anti-inflammatory, antitumor, astringent, and other beneficial properties. In one embodiment, the skin care composition comprises sodium hyaluronate. Sodium hyaluronate acts as a skin lubricant by restoring moisture and helping to prevent friction or chafing. It is a polysaccharide that is widely distributed in the extracellular matrix of connective tissue. Sodium hyaluronate can hold more water than any other natural substance, for example up to 1000 times its weight. Sodium hyaluronate can reach deep into the dermis, where it binds, retains, and attracts water. It also promotes skin / blood microcirculation and nutrient absorption. Sodium hyaluronate, thanks to its extra-large hydrating properties, can promote smoother, softer skin with reduced wrinkles, and a generally fuller appearance.

[0025] In one embodiment, the skin care composition includes dipotassium glycyrrhizinate or dipotassium glycyrrhizinate (an extract of licorice root), which can improve the appearance of dry or damaged skin by reducing flaking and restoring softness.

[0026] In one embodiment, the skin care composition includes an acetylated tocopherol, such as acetyl tetrapeptide-40, which reduces skin irritation and reduces the occurrence of facial redness caused by an excessive immune response or inflammation.

[0027] The skin care composition may further include one or more thickeners. For example, but not limited to, polyacrylamide, C13-14 isoparaffin, laureth-7, and mixtures thereof. Polyacrylamide further functions to bind ingredients and hold certain products to the skin. C13-14 isoparaffin may also act as a solvent for other ingredients. Laureth-7 may function as a surfactant / emulsifier.

[0028] The skin care composition may also contain other ingredients such as caprylyl glycol, butylene glycol, laureth-4, and phenoxyethanol. Caprylyl glycol is an antimicrobially active emollient that acts as a preservative. Butylene glycol can also function as a vehicle and viscosity reducer. Laureth-4 functions as a surfactant cleansing and solubilizer. Phenoxyethanol is a preservative.

[0029] In one particular embodiment, the composition includes water, Aloe barbadensis leaf juice; Cocos nucifera (coconut) oil; hydrolyzed glycosaminoglycans; caprylic / capric triglyceride; Melia azadirachta leaf extract; polyacrylamide; C13-14 isoparaffin; laureth-7; disodium lauriminodipropionate tocopheryl phosphate; acetyl tetrapeptide-40; caprylyl glycol; butylene glycol; sodium hyaluronate; Simmondsia chinensis (jojoba) seed oil; laureth-4; salicyloyl phytosphingosine; dipotassium glycyrrhizinate; sodium ascorbyl phosphate; and phenoxyethanol.

[0030] In one embodiment, the composition comprises about 50-70 wt% distilled water, about 7-12 wt% Aloe vera leaf juice extract and, preferably, spray-dried Aloe vera powder; about 3-9 wt% Cocos nucifera (coconut) oil; about 0.1-1 wt%, preferably about 0.2 wt% salicyloyl phytosphingosine; about 2-7 wt% hydrolyzed glycosaminoglycans; about 2-7 wt% caprylic / capric triglyceride and Melia azadirachta leaf extract; about 2-7 wt% polyacrylamide, C13-14 isoparaffin and laureth-7; about 1-5 wt% glyceryl stearate, glyceryl stearate, and glyceryl stearate. Contains about 0.1-3 wt% disodium lauriminodipropionate tocopheryl phosphate; about 1-3 wt% acetyl tetrapeptide-40 and caprylyl glycol; about 1-3 wt% butylene glycol; about 0.1-3 wt% sodium hyaluronate; about 0.1-3 wt% simmondsia chinensis (jojoba) seed oil; about 0.1-3 wt% laureth-4; about 0.1-3 wt% dipotassium glycyrrhizinate; about 0.01-1 wt% sodium ascorbyl phosphate; about 0.1-3 wt% phenoxyethanol and 0.1-1 wt% caprylyl glycol.

[0031] In one non-limiting embodiment, the skin care composition is an opaque white to off-white viscous lotion with a characteristic odor. The skin care composition has a pH range between 4.5-5.5 at 25°C. Preferably, the skin care composition has a pH between 5.00 and 6.00. In one embodiment, the skin care composition has a pH of 5.65. The skin care composition can have a viscosity of 30,000-50,000 cPs at 25°C (Brookfield LVT; spindle TE at 6 rpm). Preferably, the skin care composition has a viscosity of 30,000-40,000 cPs. The specific gravity of the skin care composition is 0.8000-1.100. Preferably, the specific gravity of the skin care composition is 0.990-1.000.

[0032] The skin care composition is stable and can cause no or only slight irritation (i.e., no or only slight acceptable skin irritation) when applied to the skin to treat skin redness. The skin care composition can be used to treat the root cause of most skin redness symptoms as well as the resulting symptoms, leading to improved patient compliance. It also has added anti-inflammatory properties for long-term symptom relief. When applied to the composition of the present invention, the term "stable" is defined as having the same color when the skin care composition is placed on a flat, inert surface (i.e., when removed from its container) when stored at room temperature (about 25°C) under normal ambient air and light conditions (i.e., air and light conditions normally present in a living room of a house) for at least one month. In addition to the color stability defined above, the stability of the skin care composition can further include, but is not limited to, physical stability (e.g., viscosity, odor, appearance, texture, etc.) and chemical stability.

[0033] This new skin care composition can be made in a variety of ways, including continuous or batch processes, in the aforementioned ratios. In one non-limiting example, laureth-4, coconut oil, and jojoba oil are heated together in one vessel, while hot distilled water, spray-dried aloe vera powder, dipotassium glycyrrhizinate, phenoxyethanol, and salicyloyl phytosphingosine are heated together and shear mixed in another vessel. When these two mixtures are at 60-90°C, the two mixtures are mixed together using high speed sweep mixing. The mixture is cooled by 15-20°C, and the thickeners, i.e., polyacrylamide, C14-C14 isoparaffin, and laureth-7, are added to the mixture and mixed well for about 5-15 minutes. Butylene glycol is then added to the mixture and mixed well. The mixture is further cooled by another 10-20°C. The remaining ingredients, except for sodium ascorbyl phosphate, are added to the cooled mixture. Then, the mixture is mixed well for another 5-15 minutes. Finally, sodium ascorbyl phosphate (or a solution of sodium ascorbyl phosphate premixed in distilled water) is added to the solution and mixed well for an additional 5-15 minutes. The resulting composition can then be filtered using filter paper and / or a membrane filter to ensure no visible residue remains.

[0034] The skin care composition may be administered by any means known in the art. Preferably, the composition is formulated as a topical preparation. According to one embodiment, the present invention is a method for treating red and inflamed skin. The method includes topically applying an effective amount of the skin care composition of the present invention to the face, neck, and any affected areas of a person suffering from skin redness as needed. The effective amount generally includes a small amount of the skin care composition. The skin care composition may be lightly rubbed into the skin at or around the affected area, particularly the face. In one embodiment, the method includes leaving the composition on the skin for a finite amount of time. In some embodiments, the skin care composition may be left on the skin and does not need to be washed off. For optimal effectiveness, the skin care composition may be used as part of a daily skin care regimen for 30-90 days, and preferably at least 60 days. In one or more embodiments, for maximum effectiveness and results, the user may apply the composition to the affected area multiple times a day, for example 2-3 times a day. In rotation, the skin care composition may be applied as needed. The skin care composition promotes soothing of the inflamed skin, moisturizes the skin, and causes a reduction in redness and inflammation. The skin care composition may act to soothe red and inflamed skin immediately after application.

[0035] It is important to avoid application of the skin care composition to the eye or the area around the eye. The method further includes instructing the user to wash their hands after application to avoid touching the eye area with fingers / fingertips that have residual agent. The user may be encouraged to wear protective gloves when applying the composition and to use a mirror to avoid spreading the product on the eye. In some embodiments, the method further includes applying the skin care composition using a suitable applicator (instead of or in addition to using a finger). Suitable applicators may include. Suitable applicators may include pads, brushes, cotton swabs, sponges, puffs, roll-on applicators, and other such devices.

[0036] In some embodiments, the method further comprises pre-cleaning (or washing) the affected area prior to application (or reapplication). Pre-cleaning may include using a gentle, non-pore clogging cleanser. A small amount of the cleanser may be rubbed onto wet skin, avoiding the eye area. The skin is then thoroughly rinsed and patted dry. In some embodiments, the cleanser may comprise a composition comprising water, PEG-80 sorbitan laurate, sodium trideceth sulfate, cocamidopropyl hydroxysultaine, PEG-150 distearate, sodium lauroamphodiacetate, sodium laureth-13 carboxylate, xanthan gum, PEG-15 cocopolyamine, sodium chloride, phenoxyethanol, and potassium sorbate.

[0037] In yet another embodiment, the skin care composition of the present invention used for treating or improving skin redness and inflammation can be included in a kit. The kit can include a container. The container can be selected from the group consisting of a bottle, a dispenser, a pressurized container, a metal tube, a plastic tube, or other type of container capable of holding the composition. The kit and / or the container can include a product indicia on its surface. The indicia can be, for example, a word, a phrase, an abbreviation, a picture, or a symbol.

[0038] The skin care composition is in a form selected from the group consisting of lotion, cream, serum, gel, stick, spray, ointment, liquid wash, foam, and mousse.The container is thus configured to dispense a predetermined amount of the composition in any of the above forms.The container may have a spray mechanism, a pump mechanism, or a squeeze mechanism.Those skilled in the art will recognize that the kit may also include instructions for application, use, and storage of the skin care composition of the present invention.

[0039] In some embodiments, the kit may further include a suitable applicator, which may be selected from the group consisting of a pad, a brush, a swab, a sponge, a puff, and a roll-on applicator. The kit may also include one or more protective gloves.

[0040] In certain other embodiments, the kit may include a first container containing a topical skin care composition of the present invention and a second container configured to hold and dispense a predetermined amount of a non-pore-clogging cleanser as described herein.

[0041] In one embodiment, the kit may include a first container containing the topical skin care composition of the present invention and another container for holding and dispensing the eyelid cleansing composition. The eyelid cleansing composition may include: (a) a mixture of antimicrobial agents that substantially eliminates at least seven strains of bacteria, the mixture including polyaminopropyl biguanide, 1,2-glycol, and a sphingoid lipid, the sphingoid lipid being salicyloyl phytosphingosine; (b) a mixed surfactant solution that maintains the eyelid cleansing composition at a pH between 5.5 and 7.5, the mixed surfactant solution having foaming power; (c) a foam stabilizer; and (d) a moisturizing agent. In yet another embodiment, the kit may include a first container containing the topical skin care composition of the present invention and one or more pre-moistened single-use cleansing pads. The pads may be pre-saturated with the eyelid cleansing composition. In yet another embodiment, the kit may include a first container that contains the topical skin care composition of the present invention and a second container that includes one or more pads for receiving the eyelid cleansing and eyelid cleansing composition or topical skin care composition. The pad may include a suitable fabric, such as a non-linting fabric material, i.e., rayon or another suitable material that can receive the eyelid cleansing composition or topical skin care composition. The pad may be a single-use disposable pad. In one embodiment, the one or more pads may be included in a sealable container. In one aspect, the sealable container may include a box or packaging. The packaging may be made of any suitable material, including plastic or metal foil material.

[0042] It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as illustrative only.

Claims

1. 1. A cream for treating rosacea in a person in need thereof comprising a therapeutically effective amount of water, aloe barbadensis leaf juice, coconut oil, hydrolyzed glycosaminoglycans, caprylic / capric triglyceride, melia azadirachta leaf extract, polyacrylamide, C13-14 isoparaffin, laureth-7, disodium lauriminodipropionate tocopheryl phosphate, acetyl tetrapeptide-40, caprylyl glycol, butylene glycol, sodium hyaluronate, simmondsia chinensis seed oil, laureth-4, salicyloyl phytosphingosine, dipotassium glycyrrhizinate, sodium ascorbyl phosphate, phenoxyethanol, and caprylyl glycol.

2. 2. The cream of claim 1, wherein the salicyloyl phytosphingosine is present at 0.1% to 1%.

3. 2. The cream of claim 1, wherein the cream has a viscosity of 30,000 to 50,000 cPs at 25°C.

4. 2. The cream of claim 1, wherein the pH of the cream is between 4.5 and 6.0.

Citation Information

Patent Citations

  • Treatment of scar tissue using lipoic acid

    JP2001522878A

  • Use of sphingoid bases in conjunction with nicotinic acid or nicotinamide in the form of depigmenting agents

    JP2007532521A

  • Spot application formulation useful in cosmetology and dermatology

    JP2007537214A

  • Sanitizing composition and method for producing the same

    JP2008508189A

  • Compounds useful in the treatment and / or care of skin, hair and / or mucous membranes and their cosmetic or pharmaceutical compositions

    JP2016502550A